Foot deformities, function in the lower extremities, and plantar pressure in patients with diabetes at high risk to develop foot ulcers

Ulla Hellstrand Tang, Roland Zügner, Vera Lisovskaja, Jon Karlsson, Kerstin Hagberg, Roy Tranberg, Ulla Hellstrand Tang, Roland Zügner, Vera Lisovskaja, Jon Karlsson, Kerstin Hagberg, Roy Tranberg

Abstract

Objective: Foot deformities, neuropathy, and dysfunction in the lower extremities are known risk factors that increase plantar peak pressure (PP) and, as a result, the risk of developing foot ulcers in patients with diabetes. However, knowledge about the prevalence of these factors is still limited. The aim of the present study was to describe the prevalence of risk factors observed in patients with diabetes without foot ulcers and to explore possible connections between the risk factors and high plantar pressure.

Patients and methods: Patients diagnosed with type 1 (n=27) or type 2 (n=47) diabetes (mean age 60.0±15.0 years) were included in this cross-sectional study. Assessments included the registration of foot deformities; test of gross function at the hip, knee, and ankle joints; a stratification of the risk of developing foot ulcers according to the Swedish National Diabetes Register; a walking test; and self-reported questionnaires including the SF-36 health survey. In-shoe PP was measured in seven regions of interests on the sole of the foot using F-Scan(®). An exploratory analysis of the association of risk factors with PP was performed.

Results: Neuropathy was present in 28 (38%), and 39 (53%) had callosities in the heel region. Low forefoot arch was present in 57 (77%). Gait-related parameters, such as the ability to walk on the forefoot or heel, were normal in all patients. Eighty percent had normal function at the hip and ankle joints. Gait velocity was 1.2±0.2 m/s. All patients were stratified to risk group 3. Hallux valgus and hallux rigidus were associated with an increase in the PP in the medial forefoot. A higher body mass index (BMI) was found to increase the PP at metatarsal heads 4 and 5. Pes planus was associated with a decrease in PP at metatarsal head 1. Neuropathy did not have a high association with PP.

Conclusions: This study identified several potential risk factors for the onset of diabetic foot ulcers (DFU). Hallux valgus and hallux rigidus appeared to increase the PP under the medial forefoot and a high BMI appeared to increase the PP under the lateral forefoot. There is a need to construct a simple, valid, and reliable assessment routine to detect potential risk factors for the onset of DFU.

Keywords: diabetic foot; foot anthropometrics; foot deformities; neuropathy; plantar pressure; prevention; risk factors.

Figures

Fig. 1
Fig. 1
Results of the SF-36 with bars (mean±SD) showing the eight domains of the SF-36 Version 1 Scale Scores for the 74 patients. PF, physical functioning; RP, role physical; BP, bodily pain; GP, general health; VT, vitality; SF, social role functioning; RE, emotional role functioning; MH, mental health. The two summary scores are presented on the right: the Physical Component Score (PCS) and the Mental Component Score (MCS). These results are normalised against a Swedish population (n=8,000) with a mean of 50 SD 10.
Fig. 2
Fig. 2
Illustration of variables associated with peak pressure (PP). The foot on the left represents the variables selected based on logarithmic PP, and the foot on the right illustrates the variables selected based on untransformed PP. The threshold value for a factor to be presented from the list was set at >0.70 (Appendix 1). In Appendices 2 and 3, the complete factor list and the direction and magnitude of their association can be found. The ranking procedure was performed for each separate region of interest (ROI). The seven ROI that were analysed were the hallux, metatarsal heads (1, 2, 4 and 5), the midfoot and the heel. The variable ‘Custom-made insoles’ is the effect this variable has on PP as compared with prefabricated insoles. The variable ‘Man’ is the effect this variable has on PP as compared with women. +, Factors that were shown to increase PP. –, Factors that were shown to decrease PP.

References

    1. Abbott CA, Carrington AL, Ashe H, Bath S, Every LC, Griffiths J, et al. The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort. Diabet Med. 2002;19:377–84.
    1. Frykberg RG, Lavery LA, Pham H, Harvey C, Harkless L, Veves A. Role of neuropathy and high foot pressures in diabetic foot ulceration. Diabetes Care. 1998;21:1714–9.
    1. Veves A, Murray HJ, Young MJ, Boulton AJ. The risk of foot ulceration in diabetic patients with high foot pressure: a prospective study. Diabetologia. 1992;35:660–3.
    1. Andersen H. Motor dysfunction in diabetes. Diabetes Metab Res Rev. 2012;28:89–92.
    1. Ribu L, Hanestad BR, Moum T, Birkeland K, Rustoen T. A comparison of the health-related quality of life in patients with diabetic foot ulcers, with a diabetes group and a nondiabetes group from the general population. Qual Life Res. 2007;16:179–89.
    1. Ragnarson Tennvall G, Apelqvist J. Health-related quality of life in patients with diabetes mellitus and foot ulcers. J Diabetes Complications. 2000;14:235–41.
    1. Raspovic KM, Wukich DK. Self-reported quality of life and diabetic foot infections. J Foot Ankle Surg. 2014;53:716–9.
    1. Boulton AJ, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J. The global burden of diabetic foot disease. Lancet. 2005;366:1719–24.
    1. Ragnarson Tennvall G, Apelqvist J. Prevention of diabetes-related foot ulcers and amputations: a cost-utility analysis based on Markov model simulations. Diabetologia. 2001;44:2077–87.
    1. Hirst M. Diabetes in 2013. The new figures. Diabetes Res Clin Pract. 2013;102:265.
    1. Bakker K, Apelqvist J, Schaper NC. Practical guidelines on the management and prevention of the diabetic foot 2011. Diabetes Metab Res Rev. 2012;28:225–31.
    1. Ragnarson Tennvall G, Apelqvist J. Health-economic consequences of diabetic foot lesions. Clin Infect Dis. 2004;39:S132–9.
    1. Tesfaye S. Neuropathy in diabetes. Medicine. 2010;38:649–55.
    1. Boyko EJ, Ahroni JH, Stensel V, Forsberg RC, Davignon DR, Smith DG. A prospective study of risk factors for diabetic foot ulcer. The Seattle Diabetic Foot Study. Diabetes Care. 1999;22:1036–42.
    1. Crawford F, Young MJ, Abbott CA, Boulton AJM, Boyko EJ, Kastenbauer T, et al. Protocol for a systematic review and individual patient data meta-analysis of prognostic factors of foot ulceration in people with diabetes: the international research collaboration for the prediction of diabetic foot ulcerations (PODUS) BMC Med Res Methodol. 2013;13:22.
    1. Veves A, Giurini JM, Logerfo FW. The diabetic foot: medical and surgical management. New York, NY: Humana Press; 2012.
    1. Birke JA, Franks BD, Foto JG. First ray joint limitation, pressure, and ulceration of the first metatarsal head in diabetes mellitus. Foot Ankle Int. 1995;16:277–84.
    1. Lavery LA, Armstrong DG, Vela SA, Quebedeaux TL, Fleischli JG. Practical criteria for screening patients at high risk for diabetic foot ulceration. Arch Intern Med. 1998;158:157–62.
    1. Lavery LA, Armstrong DG, Wunderlich RP, Tredwell J, Boulton AJ. Predictive value of foot pressure assessment as part of a population-based diabetes disease management program. Diabetes Care. 2003;26:1069–73.
    1. Formosa C, Gatt A, Chockalingam N. The importance of clinical biomechanical assessment of foot deformity and joint mobility in people living with type-2 diabetes within a primary care setting. Prim Care Diabetes. 2013;7:45–50.
    1. Holewski JJ, Moss KM, Stess RM, Graf PM, Grunfeld C. Prevalence of foot pathology and lower extremity complications in a diabetic outpatient clinic. J Rehabil Res Dev. 1989;26:35.
    1. Abouaesha F, van Schie CH, Griffths GD, Young RJ, Boulton AJ. Plantar tissue thickness is related to peak plantar pressure in the high-risk diabetic foot. Diabetes Care. 2001;24:1270–4.
    1. Hellstrand Tang U, Zügner R, Lisovskaja V, Karlsson J, Hagberg K, Tranberg R. Comparison of plantar pressure in three types of insole given to patients with diabetes at risk of developing foot ulcers – a two-year, randomized trial. J Clin Transl Endocrinol. 2014;1:121–32.
    1. Munteanu SE, Strawhorn AB, Landorf KB, Bird AR, Murley GS. A weightbearing technique for the measurement of ankle joint dorsiflexion with the knee extended is reliable. J Sci Med Sport. 2009;12:54–9.
    1. Bus SA, Waaijman R, Arts M, de Haart M, Busch-Westbroek T, van Baal J, et al. Effect of custom-made footwear on foot ulcer recurrence in diabetes: a multicenter randomized controlled trial. Diabetes Care. 2013;36:4109–16.
    1. NDR. Nationella Diabetesregistret. Årsrapport 2013 års resultat. [Swedish National Diabetes Register. Annual report 2013].2014.
    1. Boulton AJ, Armstrong DG, Albert SF, Frykberg RG, Hellman R, Kirkman MS, et al. Comprehensive foot examination and risk assessment: a report of the Task Force of the Foot Care Interest Group of the American Diabetes Association, with endorsement by the American Association of Clinical Endocrinologists. Diabetes Care. 2008;31:1679–85.
    1. McRae R. Clinical orthopaedic examination. Edinburgh: Churchill Livingstone; 2010.
    1. Sullivan M, Karlsson J, Taft C, Ware JE., Jr . SF-36 hälsoenkät: svensk manual och tolkningsguide [Swedish manual and interpretation guide] Gothenburg: Göteborg Sahlgrenska sjukhuset, Sektionen för vårdforskning; 2002.
    1. Gandek B, Kaasa S, Leplège A, Sullivan M, Ware JE, Aaronson NK, et al. Tests of data quality, scaling assumptions, and reliability of the SF-36 in eleven countries. J Clin Epidemiol. 1998;51:1149–58.
    1. Alonso J, Apolone G, Bucquet D, Keller S, Sullivan M, Wagner A. International quality of life assessment (IQOLA) project. Qual Life Res. 1992;1:349–51.
    1. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med Care. 1992;30:473–83.
    1. Zimny S, Schatz H, Pfohl M. The role of limited joint mobility in diabetic patients with an at-risk foot. Diabetes Care. 2004;27:942–6.
    1. McPoil T, Vicenzino B, Cornwall M, Collins N. Can foot anthropometric measurements predict dynamic plantar surface contact area? J Foot Ankle Res. 2009;2:28.
    1. Verbeke G, Molenberghs G. Linear mixed models for longitudinal data. New York, NY: Springer; 2000.
    1. Ahroni JH, Boyko EJ, Forsberg RC. Clinical correlates of plantar pressure among diabetic veterans. Diabetes Care. 1999;22:965–72.
    1. Guiotto A, Sawacha Z, Guarneri G, Cristoferi G, Avogaro A, Cobelli C. The role of foot morphology on foot function in diabetic subjects with or without neuropathy. Gait Posture. 2013;37:603–10.
    1. Kärvestedt L, Mårtensson E, Grill V, Elofsson S, von Wendt G, Hamsten A, et al. The prevalence of peripheral neuropathy in a population-based study of patients with type 2 diabetes in Sweden. J Diabetes Complications. 2011;25:97–106.
    1. Apelqvist J, Larsson J. What is the most effective way to reduce incidence of amputation in the diabetic foot. Diabetes Metab Res Rev. 2000;16:S75–83.
    1. Majumder A, Chatterjee S, Maji D. Peripheral neuropathy in diabetes. J Indian Med Assoc. 2013;111:382, 384–6.
    1. Leese G, Schofield C, McMurray B, Libby G, Golden J, MacAlpine R, et al. Scottish foot ulcer risk score predicts foot ulcer healing in a regional specialist foot clinic. Diabetes Care. 2007;30:2064–9.
    1. Wylie-Rosett J. Assessment of documented foot examinations for patients with diabetes in inner-city primary care clinics. Arch Fam Med. 1995;4:46–50.
    1. Bailey TS, Yu HM, Rayfield EJ. Patterns of foot examination in a diabetes clinic. Am J Med. 1985;78:371–4.
    1. Baker N, Kenny C. Prevention, screening and referral of the diabetic foot in primary care. Diabetes Primary Care. 2014;16:307–16.
    1. Leese GP, Reid F, Green V, McAlpine R, Cunningham S, Emslie-Smith AM, et al. Stratification of foot ulcer risk in patients with diabetes: a population-based study. Int J Clin Pract. 2006;60:541–5.
    1. Kennon B, Leese GP, Cochrane L, Colhoun H, Wild S, Stang D, et al. Reduced incidence of lower-extremity amputations in people with diabetes in Scotland: a nationwide study. Diabetes Care. 2012;35:2588–90.
    1. Västra Götalandsregionen. Regionalt vårdprogram/riklinjer. Diabetesfoten 2008 [Regional guidelines on the Diabetic Foot 2008] Available from: [cited 10 April 2015].
    1. Kozakai R, Tsuzuku S, Yabe K, Ando F, Niino N, Shimokata H. Age-related changes in gait velocity and leg extension power in middle-aged and elderly people. J Epidemiol. 2000;10:S77.
    1. Bohannon RW. Comfortable and maximum walking speed of adults aged 20–79 years: reference values and determinants. Age Ageing. 1997;26:15–9.
    1. Allet L, Armand S, Golay A, Monnin D, de Bie RA, de Bruin ED. Gait characteristics of diabetic patients: a systematic review. Diabetes Metab Res Rev. 2008;24:173–91.
    1. Rubin RR, Peyrot M. Quality of life and diabetes. Diabetes Metab Res Rev. 1999;15:205–18.

Source: PubMed

3
Tilaa